source
- Caribou Biosciences shuts down after failing to fund late-stage CAR-T lymphoma trialCaribou Biosciences, a biotech co-founded by Nobel laureate Jennifer Doudna, announced it is shutting down. The closure follows the company's inability to raise the funding required for a Phase 3…
- Venture capital continues to flow into biopharma in Q3 2026, favoring later-stage and AI-driven companiesVenture capital funding into biopharma topped $16 billion in the first half of 2026 and kept rising in the third quarter, according to industry sources. Investors remain selective, directing money…